1-3 of 3
Ingo Müller
Close
Sort by
Journal Articles

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany

Clinical Trials & Observations
Peter Bader, Claudia Rossig, Martin Hutter, Francis Ayuketang Ayuk, Claudia D. Baldus, Veit L. Bücklein, Halvard Bonig, Gunnar Cario, Hermann Einsele, Udo Holtick, Christian Koenecke, Shahrzad Bakhtiar, Annette Künkele, Roland Meisel, Fabian Müller, Ingo Müller, Olaf Penack, Eva Rettinger, Martin G. Sauer, Paul-Gerhardt Schlegel, Jan Soerensen, Arend von Stackelberg, Brigitte Strahm, Julia Hauer, Tobias Feuchtinger, Andrea Jarisch
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2436–2448.
https://doi.org/10.1182/bloodadvances.2022008981
Published: 2023
Includes: Supplemental data
Journal Articles

MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity

Kerstin Schütze, Miriam Groß, Kerstin Cornils, Katharina Wustrau, Sonja Schneppenheim, Henning Lenhartz, G. Christoph Korenke, Gritta Janka, Svea Ledig, Ingo Müller, Stephan Ehl, Kai Lehmberg
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1531–1535.
https://doi.org/10.1182/bloodadvances.2022008195
Published: 2023
Includes: Supplemental data
Journal Articles

Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia

Clinical Trials & Observations
Brigitte Strahm, Felicia Loewecke, Charlotte M. Niemeyer, Michael Albert, Marc Ansari, Peter Bader, Yves Bertrand, Birgit Burkhardt, Lydie M. Da Costa, Alina Ferster, Alexandra Fischer, Tayfun Güngör, Bernd Gruhn, Ina Hainmann, Friedrich Kapp, Peter Lang, Ingo Müller, Ansgar Schulz, Amina Szvetnik, Marcin Wlodarski, Peter Noellke, Thierry Leblanc, Jean-Hugues Dalle
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1760–1769.
https://doi.org/10.1182/bloodadvances.2019001210
Published: 2020